Beimei Pharmaceutical production base (Beimei Pharmaceutical wholly-owned subsidiary - Jiangsu Beimei Pharmaceutical Co., Ltd.) was successfully settled in Lianyungang Free Trade Zone， International Pharmaceutical Innovation Industrial Park

Obtained Certificate of Intellectual Property Management System Certification

Beimei (Shenzhen) Innovation Centreput into service

Oselavir®(Oseltamivir Phosphate for Suspension) successfully wonin the eighth roundof National Pharmaceutical VBP

Awarded with the title of Shenzhen Innovation-driven SME Enterprise

PRESOMID®(Esomeprazole Magnesium for Delayed-Release Oral Suspension) approved for marketing

Passed the certificationof National High-tech Enterprise

Signed up an exclusive license and supply agreement in China with SyriMed, UKfor a children's skeletal muscle relaxation oral solution

Signed up an exclusive license and supply agreement in China with Ciplafor one newborn-specific product